HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D D Bigner Selected Research

Radiotherapy

5/2001Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab')(2): a case study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D D Bigner Research Topics

Disease

17Neoplasms (Cancer)
09/2010 - 01/2000
17Glioma (Gliomas)
12/2009 - 01/2000
7Glioblastoma (Glioblastoma Multiforme)
10/2012 - 01/2000
5Brain Neoplasms (Brain Tumor)
09/2001 - 01/2000
4Medulloblastoma
06/2009 - 07/2001
4Central Nervous System Neoplasms
09/2001 - 01/2000
2Astrocytoma (Pilocytic Astrocytoma)
09/2001 - 02/2000
1Neoplasm Metastasis (Metastasis)
09/2010
1Squamous Cell Carcinoma of Head and Neck
09/2010
1Head and Neck Neoplasms (Head and Neck Cancer)
09/2010
1Hypoxia (Hypoxemia)
12/2009
1Hypertension (High Blood Pressure)
12/2009
1Ataxia Telangiectasia (Louis Bar Syndrome)
06/2009
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2001
1Ependymoma
07/2001
1Meningitis
05/2001
1Bilateral Hearing Loss
05/2001
1Neuroectodermal Tumors (Neuroectodermal Tumor)
05/2001
1Melanoma (Melanoma, Malignant)
05/2001
1Thrombocytopenia (Thrombopenia)
10/2000
1Neutropenia
10/2000
1Oligodendroglioma
08/2000
1Experimental Melanoma
06/2000
1Pathologic Processes
06/2000
1Carcinoma (Carcinomatosis)
01/2000

Drug/Important Bio-Agent (IBA)

7epidermal growth factor receptor VIIIIBA
09/2010 - 01/2000
6ErbB Receptors (EGF Receptor)IBA
09/2010 - 01/2000
5Monoclonal AntibodiesIBA
09/2010 - 03/2000
4Carmustine (FIVB)FDA Link
06/2009 - 01/2000
3Peptides (Polypeptides)IBA
10/2001 - 08/2000
3Irinotecan (Camptosar)FDA LinkGeneric
07/2001 - 01/2000
3AntigensIBA
09/2000 - 06/2000
2Bevacizumab (Avastin)FDA Link
10/2012 - 12/2009
2Epidermal Growth Factor (EGF)IBA
09/2010 - 06/2001
2Phosphotransferases (Kinase)IBA
06/2009 - 06/2007
2Glycoproteins (Glycoprotein)IBA
05/2008 - 06/2007
2Proteins (Proteins, Gene)FDA Link
06/2007 - 08/2000
2Amino AcidsFDA Link
10/2001 - 08/2000
2Procarbazine (Matulane)FDA Link
09/2001 - 07/2001
2CamptothecinIBA
07/2001 - 10/2000
2O(6)-benzylguanineIBA
10/2000 - 01/2000
2Temozolomide (Temodar)FDA LinkGeneric
10/2000 - 10/2000
2TenascinIBA
08/2000 - 03/2000
1Antineoplastic Agents (Antineoplastics)IBA
09/2010
1Cetuximab (Erbitux)FDA Link
09/2010
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
09/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2009
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2009
1Carbonic Anhydrase IXIBA
12/2009
1Etoposide (VP 16)FDA LinkGeneric
12/2009
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2008
1Oxidoreductases (Dehydrogenase)IBA
05/2008
1AldehydesIBA
05/2008
1Small Interfering RNA (siRNA)IBA
06/2007
1Cysteine (L-Cysteine)FDA Link
06/2007
1antineoplaston A10 (A 10)IBA
11/2001
1Pharmaceutical PreparationsIBA
11/2001
1irofulvenIBA
11/2001
1Hydroxyl RadicalIBA
09/2001
1carbazoleIBA
09/2001
1edotecarin (J 107088)IBA
09/2001
1Topoisomerase I InhibitorsIBA
09/2001
1Busulfan (Busulfex)FDA Link
07/2001
1cositecanIBA
07/2001
1Topotecan (Hycamtin)FDA LinkGeneric
07/2001
1AgarIBA
05/2001
1Sulfates (Sulfates, Inorganic)IBA
05/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2001
1Proteoglycans (Proteoglycan)IBA
05/2001
1Telomerase (Telomerase Reverse Transcriptase)IBA
05/2001
1Biological ProductsIBA
05/2001
1Iodine-131IBA
11/2000
1imidazoleIBA
10/2000
1Tumor Biomarkers (Tumor Markers)IBA
09/2000
1LigandsIBA
08/2000
1EpitopesIBA
06/2000
1Immunoglobulin G (IgG)IBA
06/2000
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2000
1CytokinesIBA
02/2000
1Cytotoxins (Cytolysins)IBA
01/2000
1AntibodiesIBA
01/2000
1Radioisotopes (Radionuclides)IBA
01/2000
1Cell Surface ReceptorsIBA
01/2000

Therapy/Procedure

8Therapeutics
10/2012 - 01/2000
3Drug Therapy (Chemotherapy)
12/2009 - 11/2000
3Immunotherapy
12/2000 - 06/2000
1Aftercare (After-Treatment)
05/2001
1Radiotherapy
05/2001
1Injections
03/2000